Hormone Replacement Therapy-Related Thrombosis
Blood clots associated with menopausal hormone therapy
Quick Facts
- Type: Medication-related vascular condition
- Linked to: Estrogen-containing hormone replacement therapy
- Lower risk with: Skin patches and gels versus tablets
- Seek urgent care: Leg swelling, chest pain, sudden breathlessness
Overview
Hormone replacement therapy (HRT) is used to relieve menopausal symptoms such as hot flashes, night sweats, and vaginal dryness. Most forms contain estrogen, sometimes combined with a progestogen. Estrogen can slightly increase the blood's tendency to clot, so HRT carries a small increase in the risk of venous thromboembolism, meaning clots in the deep veins (deep vein thrombosis) or lungs (pulmonary embolism).
The size of this risk depends heavily on how the estrogen is taken. Estrogen swallowed as a tablet passes through the liver and raises clot risk more than estrogen absorbed through the skin as a patch or gel, which has little or no measurable effect on clotting. For most people the overall risk is low, and HRT decisions weigh benefits against individual risk factors.
Symptoms
Symptoms depend on where a clot forms. A clot in a leg vein typically causes:
- Swelling, usually of one leg
- Pain or tenderness, often in the calf
- Warmth, redness, or discoloration of the skin
A clot that travels to the lungs is an emergency and may cause:
- Sudden shortness of breath
- Chest pain that worsens with breathing
- A fast heartbeat
- Coughing, sometimes with blood
- Lightheadedness or fainting
Sudden severe headache, vision changes, or one-sided weakness could signal a clot or stroke and need emergency care.
Causes
The increased clotting tendency comes from estrogen, which changes the levels of clotting proteins, particularly when taken as a tablet.
- Oral (tablet) estrogen: Passes through the liver first and raises clot risk more than skin-based forms.
- Skin patches and gels (transdermal): Absorbed directly into the bloodstream, bypassing the liver, with little measurable effect on clotting.
- Individual risk factors: Obesity, older age, and inherited clotting disorders add to the baseline risk.
Vaginal estrogen used for local symptoms is absorbed in very small amounts and is not generally associated with increased clot risk.
Risk Factors
- Oral (tablet) HRT rather than patches or gels
- Obesity
- A personal or family history of blood clots
- An inherited clotting disorder (thrombophilia)
- Older age
- Recent surgery, prolonged immobility, or long-distance travel
Diagnosis
A suspected clot is investigated the same way regardless of cause.
- Leg ultrasound: The main test for a suspected deep vein thrombosis.
- Blood test (D-dimer): Can help rule out a clot in lower-risk situations.
- Chest imaging: A specialized lung scan if a pulmonary embolism is suspected.
Before starting HRT, clinicians assess personal and family clotting history to choose the safest form and route.
Treatment
A confirmed clot is treated with blood thinners, and the HRT is reviewed.
- Anticoagulants: Blood-thinning medication to treat the clot and prevent it from recurring.
- Reviewing HRT: Oral estrogen is usually stopped; a switch to a transdermal patch or gel, or to non-hormonal symptom treatments, may be considered.
- Hospital care: A large clot in the lungs may require more intensive treatment.
Many people who still need menopausal symptom relief after a clot can use lower-risk skin-based estrogen under specialist guidance, but this is decided individually.
Prevention
- Discuss your personal and family clotting history before starting HRT
- Consider transdermal (patch or gel) estrogen, which carries lower clot risk than tablets
- Keep to the lowest effective dose for symptom relief
- Maintain a healthy weight and stay active
- Tell health professionals you take HRT before surgery or long periods of immobility
When to See a Doctor
Seek emergency care if you develop signs of a clot while on HRT, including:
- Swelling, pain, or warmth in one leg
- Sudden shortness of breath or chest pain when breathing
- Coughing up blood
- Sudden severe headache, vision loss, or weakness on one side
These symptoms can be life-threatening and need immediate medical attention. Tell the medical team you are using hormone replacement therapy.
Frequently Asked Questions
Does HRT increase the risk of blood clots?
Estrogen-containing HRT can slightly raise the risk of blood clots because estrogen increases the blood's clotting tendency. The risk is mainly with tablets; skin patches and gels have little or no measurable effect on clotting and are considered lower risk.
Which type of HRT has the lowest clot risk?
Estrogen absorbed through the skin as a patch or gel carries a lower clot risk than estrogen swallowed as a tablet, because it bypasses the liver. Vaginal estrogen used for local symptoms is absorbed in very small amounts and is not generally linked to clots.
What are the warning signs of a clot on HRT?
Swelling, pain, or warmth in one leg can signal a leg clot, while sudden breathlessness, chest pain when breathing, or coughing up blood can mean a clot in the lungs. Sudden severe headache or one-sided weakness also needs emergency care.
Who is at higher risk of clots on HRT?
People who are very overweight, those with a personal or family history of clots or an inherited clotting disorder, older individuals, and those using oral rather than skin-based estrogen are at higher risk. A clinician can help weigh the risks.
Can I use HRT after having a blood clot?
Oral estrogen is usually avoided after a clot, but some people who still need menopausal symptom relief can use lower-risk skin-based estrogen or non-hormonal treatments under specialist guidance. This is decided on an individual basis.
References
- MedlinePlus, U.S. National Library of Medicine. Hormone replacement therapy.
- North American Menopause Society. Menopausal hormone therapy.
- Mayo Clinic. Hormone therapy: Is it right for you?